Literature DB >> 17230064

Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: results of the Malaysia-Singapore Leukemia Study Group.

Hany Ariffin1, Siew-Peng Chen, Cecilia S Kwok, Thuan-Chong Quah, Hai-Peng Lin, Allen E J Yeoh.   

Abstract

Childhood acute lymphoblastic leukemia (ALL) is clinically heterogeneous with prognostically and biologically distinct subtypes. Although racial differences in frequency of different types of childhood ALL have been reported, many are confounded by selected or limited population samples. The Malaysia-Singapore (MA-SPORE) Leukemia Study Group provided a unique platform for the study of the frequency of major subgroups of childhood ALL in a large cohort of unselected multiethnic Asian children. Screening for the prognostically important chromosome abnormalities (TEL-AML1, BCR-ABL, E2A-PBX1, and MLL) using multiplex reverse-transcription polymerase chain reaction was performed on 299 consecutive patients with ALL at 3 study centers (236 de novo, 63 at relapse), with the ethnic composition predominantly Chinese (51.8%) and Malay (34.8%). Reverse-transcription polymerase chain reaction was successful in 278 (93%) of cases screened. The commonest fusion transcript was TEL-AML1 (19.1%) followed by BCR-ABL (7.8%), MLL rearrangements (4.2%), and E2A-PBX1 (3.1%). Chinese have a significantly lower frequency of TEL-AML1 (13.3% in de novo patients) compared with Malays (22.2%) and Indians (21.7%) (P=0.04). Malays have a lower frequency of T-ALL (6.2%) compared with the Chinese and Indians (9.8%). Both Malays (7.4%) and Chinese (5.0%) have significantly higher frequency of BCR-ABL compared with the Indian population (P<0.05) despite a similar median age at presentation. Our study suggests that there are indeed significant and important racial differences in the frequency of subtypes of childhood ALL. Comprehensive subgrouping of childhood ALL may reveal interesting population frequency differences of the various subtypes, their risk factors and hopefully, its etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230064     DOI: 10.1097/MPH.0b013e318030ac4c

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients.

Authors:  Ravi Ramalingam; Harpreet Kaur; Julius Xavier Scott; Latha M Sneha; Ganeshprasad Arunkumar; Arathi Srinivasan; Solomon F D Paul
Journal:  Cancer Chemother Pharmacol       Date:  2022-02-14       Impact factor: 3.333

2.  High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.

Authors:  Zafar Iqbal; Tanveer Akhtar; Tashfin Awan; Aamer Aleem; Noreen Sabir; Mahmood Rasool; Muhammad Absar; Afia M Akram; Masood A Shammas; Ijaz H Shah; Muhammad Khalid; Abid S Taj; Abid Jameel; Abdullah Alanazi; Ammara T Gill; Jamil Amjad Hashmi; Akhtar Hussain; Muhammad Farooq Sabar; Ahmad M Khalid; Mehmood Hussain Qazi; Sajjad Karim; Muhammad Hassan Siddiqi; Aamir Mahmood; Mudassar Iqbal; Anjum Saeed; Muhammad Imran Irfan
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

Review 3.  The Prenatal Origin of Childhood Leukemia: Potential Applications for Epidemiology and Newborn Screening.

Authors:  Erin L Marcotte; Logan G Spector; Daniela P Mendes-de-Almeida; Heather H Nelson
Journal:  Front Pediatr       Date:  2021-04-23       Impact factor: 3.418

4.  A comprehensive analysis of breakpoint cluster region-abelson fusion oncogene splice variants in chronic myeloid leukemia and their correlation with disease biology.

Authors:  Zafar Iqbal
Journal:  Indian J Hum Genet       Date:  2014-01

5.  Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL.

Authors:  Janet Flores-Lujano; David Aldebarán Duarte-Rodríguez; Elva Jiménez-Hernández; Jorge Alfonso Martín-Trejo; Aldo Allende-López; José Gabriel Peñaloza-González; María Luisa Pérez-Saldivar; Aurora Medina-Sanson; José Refugio Torres-Nava; Karina Anastacia Solís-Labastida; Luz Victoria Flores-Villegas; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Martha Margarita Velázquez-Aviña; Laura Elizabeth Merino-Pasaye; Nora Nancy Núñez-Villegas; Ana Itamar González-Ávila; María de Los Ángeles Del Campo-Martínez; Martha Alvarado-Ibarra; Vilma Carolina Bekker-Méndez; Rocío Cárdenas-Cardos; Silvia Jiménez-Morales; Roberto Rivera-Luna; Haydee Rosas-Vargas; Norma C López-Santiago; Angélica Rangel-López; Alfredo Hidalgo-Miranda; Elizabeth Vega; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; José Arellano-Galindo; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré
Journal:  Front Public Health       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.